A Phase I/II clinical trial of Carbon-ion radiotherapy in 4 fractions over 1 week for patients with renal cell carcinoma
Phase 1
- Conditions
- Renal cell carcinoma
- Registration Number
- JPRN-UMIN000029469
- Lead Sponsor
- ational Institutes for Quantum Science and Technology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1)target area that had been treated by other radiation therapy 2) After the start of molecular targetting therapy 3) irradiated dose to gastrointestinal tract is more than 60% of prescribed dose 4) maximum tumor diameter > 15cm 5) dialyzed RCC 6) presence of active double cancers other than RCC 7) serious medical or psychological condition precluding the safe administration of the treatment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Acute adverse effect (within 90 days)
- Secondary Outcome Measures
Name Time Method late adverse effect, local control, cancer specific survival, overall survival, QO